• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

越南同一家庭内幽门螺杆菌感染和根除治疗的结局:一项非随机研究的结果。

Helicobacter pylori infection and eradication outcomes among Vietnamese patients in the same households: Findings from a non-randomized study.

机构信息

Institute of Gastroenterology and Hepatology, Hanoi, Vietnam.

Internal Medicine Faculty, Hanoi Medical University, Hanoi, Vietnam.

出版信息

PLoS One. 2021 Nov 24;16(11):e0260454. doi: 10.1371/journal.pone.0260454. eCollection 2021.

DOI:10.1371/journal.pone.0260454
PMID:34818349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8612553/
Abstract

OBJECTIVE

Familial transmission can possibly influence the infection and treatment of Helicobacter pylori. This study aimed to describe the prevalence of H. pylori infection and outcomes of eradication treatment among Vietnamese patients who live in the same households.

METHODS

We conducted a prospective cohort study of Vietnamese household members with upper gastrointestinal complaints. Participants received esophagogastroduodenoscopy and H. pylori testing. The H. pylori-positive patients were treated and asked to return for follow-up within 4 months. To explore factors associated with H. pylori infection at baseline, we performed multilevel logistic regression to account for the clustering effect of living in the same households. To explore factors associated with eradication failure, we used Poisson regression with robust variance estimation to estimate the risk ratio.

RESULTS

The prevalence of H. pylori infection was 83.5% and highest among children <12 years old (92.2%) in 1,272 patients from 482 households. There were variations in H. pylori infection across households (intraclass correlation = 0.14, 95% confidence interval (CI) 0.05, 0.33). Children aged <12 years had higher odds of H. pylori infection (odds ratio = 3.41, 95%CI 2.11, 5.50). At follow-up, H. pylori was eradicated in 264 of 341 patients (77.4%). The risk of eradication failure was lower for the sequential regimen with tetracycline.

CONCLUSION

H. pylori infection was common among people living in the same households. Eradication success for H. pylori was higher for the tetracycline sequential regimen. More research should be focused on how family factors influence H. pylori infection and on eradication treatment.

摘要

目的

家族传播可能会影响幽门螺杆菌的感染和治疗。本研究旨在描述生活在同一家庭的越南患者中幽门螺杆菌感染的流行情况和根除治疗的结果。

方法

我们对有上消化道症状的越南家庭成员进行了前瞻性队列研究。参与者接受了食管胃十二指肠镜检查和幽门螺杆菌检测。幽门螺杆菌阳性患者接受治疗,并要求在 4 个月内进行随访。为了探讨与基线时幽门螺杆菌感染相关的因素,我们采用多水平逻辑回归来解释生活在同一家庭的聚类效应。为了探讨与根除失败相关的因素,我们使用具有稳健方差估计的泊松回归来估计风险比。

结果

在 482 户家庭的 1272 名患者中,幽门螺杆菌感染的患病率为 83.5%,年龄<12 岁的儿童最高(92.2%)。家庭之间的幽门螺杆菌感染存在差异(组内相关系数=0.14,95%置信区间[CI]0.05,0.33)。年龄<12 岁的儿童幽门螺杆菌感染的可能性更高(比值比[OR]=3.41,95%CI 2.11,5.50)。在随访时,341 名患者中有 264 名(77.4%)幽门螺杆菌被根除。四环素序贯方案根除失败的风险较低。

结论

生活在同一家庭的人群中幽门螺杆菌感染很常见。四环素序贯方案对幽门螺杆菌的根除成功率更高。应更多地关注家庭因素如何影响幽门螺杆菌感染和根除治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e78/8612553/9e9cc63f09d3/pone.0260454.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e78/8612553/9e9cc63f09d3/pone.0260454.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e78/8612553/9e9cc63f09d3/pone.0260454.g001.jpg

相似文献

1
Helicobacter pylori infection and eradication outcomes among Vietnamese patients in the same households: Findings from a non-randomized study.越南同一家庭内幽门螺杆菌感染和根除治疗的结局:一项非随机研究的结果。
PLoS One. 2021 Nov 24;16(11):e0260454. doi: 10.1371/journal.pone.0260454. eCollection 2021.
2
Efficacy of second-line regimens for eradication treatment: a systemic review and network meta-analysis.二线方案在根治性治疗中的疗效:系统评价和网络荟萃分析。
BMJ Open Gastroenterol. 2020 Sep;7(1). doi: 10.1136/bmjgast-2020-000472.
3
Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.序贯疗法与含阿莫西林/四环素的铋剂四联疗法一线根除幽门螺杆菌的比较:一项前瞻性、多中心、随机临床试验。
BMC Gastroenterol. 2016 Jul 26;16(1):79. doi: 10.1186/s12876-016-0490-8.
4
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for infection and predictors of failed eradication.呋喃唑酮和阿莫西林四联疗法治疗感染的结果及根除失败的预测因素。
World J Gastroenterol. 2018 Oct 28;24(40):4596-4605. doi: 10.3748/wjg.v24.i40.4596.
5
Bismuth-based therapies for the first step eradication of Helicobacter pylori.铋剂疗法用于第一步根除幽门螺杆菌。
Turk J Gastroenterol. 2006 Jun;17(2):90-3.
6
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.在非铋剂四联疗法失败后,左氧氟沙星、铋剂、阿莫西林和埃索美拉唑作为二线幽门螺杆菌治疗方案。
Dig Liver Dis. 2016 May;48(5):506-511. doi: 10.1016/j.dld.2016.01.002. Epub 2016 Jan 15.
7
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.汞合金补牙材料对采用联合、四联及基于左氧氟沙星疗法治疗的患者幽门螺杆菌感染发生率及幽门螺杆菌根除率的影响。
Eur J Gastroenterol Hepatol. 2015 Jul;27(7):769-75. doi: 10.1097/MEG.0000000000000372.
8
Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.铋剂联合次枸橼酸铋、甲硝唑和四环素的三联疗法根除幽门螺杆菌:一项随机、安慰剂对照、双盲研究。
Can J Gastroenterol. 2000 Jul-Aug;14(7):599-602. doi: 10.1155/2000/690307.
9
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.两种含四环素或克拉霉素的四联二线幽门螺杆菌根除疗法的有效性。
Aliment Pharmacol Ther. 2002 Mar;16(3):569-75. doi: 10.1046/j.1365-2036.2002.01220.x.
10
Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study).在不丹资源有限地区,奥美拉唑、四环素和每日 4 次阿莫西林给药在幽门螺杆菌根除中的疗效:一项前瞻性随机试验(BHUTAN 研究)。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1109-1114. doi: 10.31557/APJCP.2020.21.4.1109.

引用本文的文献

1
Diminishing Efficacy of Second-Line Levofloxacin-Based Quadruple Therapy in Eradication: A Prospective Real-World Study in Vietnam Amid Rising Antibiotic Resistance.二线左氧氟沙星四联疗法根除幽门螺杆菌的疗效降低:越南抗生素耐药性上升背景下的一项前瞻性真实世界研究
Antibiotics (Basel). 2025 Aug 14;14(8):826. doi: 10.3390/antibiotics14080826.
2
Prevalence, Predictors, and Treatment Outcomes of Anemia in Vietnamese School-Age Children With Helicobacter pylori Infection.越南幽门螺杆菌感染学龄儿童贫血的患病率、预测因素及治疗结果
Cureus. 2024 Sep 15;16(9):e69473. doi: 10.7759/cureus.69473. eCollection 2024 Sep.
3
Infection and Peptic Ulcer Disease in Symptomatic Children in Southern Vietnam: A Prospective Multicenter Study.

本文引用的文献

1
Global whole family based- eradication strategy to prevent its related diseases and gastric cancer.全球范围内以家庭为基础的根除策略,以预防其相关疾病和胃癌。
World J Gastroenterol. 2020 Mar 14;26(10):995-1004. doi: 10.3748/wjg.v26.i10.995.
2
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.日本幽门螺杆菌感染管理指南:2016 年修订版。
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
3
Helicobacter pylori Infection in Children and Adolescents.儿童和青少年幽门螺杆菌感染。
越南南部有症状儿童的感染与消化性溃疡疾病:一项前瞻性多中心研究
Healthcare (Basel). 2023 Jun 5;11(11):1658. doi: 10.3390/healthcare11111658.
4
Vietnam Association of Gastroenterology (VNAGE) consensus on the management of infection.越南胃肠病学协会(VNAGE)关于感染管理的共识
Front Med (Lausanne). 2023 Jan 12;9:1065045. doi: 10.3389/fmed.2022.1065045. eCollection 2022.
5
Antibiotic Resistance of in Patients with Peptic Ulcer.在消化性溃疡患者中的 抗生素耐药性。
Medicina (Kaunas). 2022 Dec 20;59(1):6. doi: 10.3390/medicina59010006.
Adv Exp Med Biol. 2019;1149:107-120. doi: 10.1007/5584_2019_361.
4
Management of Antibiotic-Resistant Infection: Perspectives from Vietnam.抗生素耐药感染的管理:来自越南的观点。
Gut Liver. 2019 Sep 15;13(5):483-497. doi: 10.5009/gnl18137.
5
Epidemiology of gastric cancer: global trends, risk factors and prevention.胃癌流行病学:全球趋势、风险因素与预防
Prz Gastroenterol. 2019;14(1):26-38. doi: 10.5114/pg.2018.80001. Epub 2018 Nov 28.
6
Helicobacter pylori infections in Ethiopia; prevalence and associated factors: a systematic review and meta-analysis.埃塞俄比亚的幽门螺杆菌感染:患病率及相关因素:一项系统评价与荟萃分析
BMC Gastroenterol. 2019 Jan 10;19(1):8. doi: 10.1186/s12876-018-0927-3.
7
Molecular Epidemiology of Helicobacter pylori Infection in a Minor Ethnic Group of Vietnam: A Multiethnic, Population-Based Study.越南少数民族人群幽门螺杆菌感染的分子流行病学:一项多民族、基于人群的研究。
Int J Mol Sci. 2018 Mar 1;19(3):708. doi: 10.3390/ijms19030708.
8
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.全球幽门螺杆菌感染率:系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):420-429. doi: 10.1053/j.gastro.2017.04.022. Epub 2017 Apr 27.
9
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南:幽门螺杆菌感染的治疗
Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10.
10
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.